AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

2019 US Endocrine Function Testing Market Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers - ResearchAndMarkets.com

May 6, 2019

DUBLIN--(BUSINESS WIRE)--May 6, 2019--The “2019 US Endocrine Function Testing Market Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers” report has been added to ResearchAndMarkets.com’s offering.

This new 271-page report provides a comprehensive analysis in the US endocrine function market, including emerging tests, Technologies, instrumentation, sales forecasts by country, market shares and strategic profiles of leading suppliers.

The report provides test volume and sales forecasts by country and market segment for the following assays:
Cortisol, Estradiol, FSH, HCG, Gastrin, LH, Progesterone, PTH/IO PTH, Prolactin, T3, T3 Uptake, Free T3, T4, Free T4, TBG, Testosterone, Thyroglobulin Ab, TPO Ab and TSH.

During the next five years, the endocrine function testing market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic Technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.

This report is a unique market and technology assessment designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study explores future trends; provides test volume and sales forecasts; compares features of leading analyzers; and profiles key competitors.

Companies Mentioned

  • Abbott Laboratories
  • Agilent Technologies
  • Beckman Coulter/Danaher
  • bioMerieux
  • Bio-Rad
  • DiaSorin
  • Eiken Chemical
  • Fujirebio
  • Grifols
  • Instrumentation Laboratory/Werfen
  • Kyowa Medex
  • Ortho-Clinical Diagnostics
  • PerkinElmer
  • Quest Diagnostics
  • Roche
  • Siemens Healthineers
  • Sysmex
  • Thermo Fisher
  • Tosoh
  • Wako

For more information about this report visit https://www.researchandmarkets.com/r/x1prg

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

View source version on businesswire.com:https://www.businesswire.com/news/home/20190506005304/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Diagnostics

KEYWORD: UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: HEALTH OTHER HEALTH

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 05/06/2019 05:21 AM/DISC: 05/06/2019 05:21 AM

http://www.businesswire.com/news/home/20190506005304/en